PBE vs. PBD
PBE (Invesco Dynamic Biotechnology & Genome ETF) and PBD (Invesco Global Clean Energy ETF) are both exchange-traded funds - PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX), while PBD is a Alternative Energy Equities fund tracking the WilderHill New Energy Global Innovation index. Both are passively managed. Over the past 10 years, PBE returned 7.55%/yr vs 9.45%/yr for PBD. A 0.55 correlation means they provide meaningful diversification when combined. PBE charges 0.59%/yr vs 0.75%/yr for PBD.
Performance
PBE vs. PBD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 0.58% return, which is significantly lower than PBD's 38.50% return. Over the past 10 years, PBE has underperformed PBD with an annualized return of 7.55%, while PBD has yielded a comparatively higher 9.45% annualized return.
PBE
- 1D
- 2.04%
- 1M
- 2.68%
- YTD
- 0.58%
- 6M
- 1.15%
- 1Y
- 30.26%
- 3Y*
- 10.44%
- 5Y*
- 3.06%
- 10Y*
- 7.55%
PBD
- 1D
- -0.93%
- 1M
- 6.10%
- YTD
- 38.50%
- 6M
- 39.82%
- 1Y
- 92.04%
- 3Y*
- 8.96%
- 5Y*
- -3.66%
- 10Y*
- 9.45%
PBE vs. PBD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.58% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
PBD Invesco Global Clean Energy ETF | 38.50% | 43.65% | -26.39% | -10.69% | -29.70% | -22.30% | 145.46% | 40.00% | -19.32% | 28.72% |
Correlation
The correlation between PBE and PBD is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.41 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.56 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2007 | 0.55 |
The correlation between PBE and PBD shifts across timeframes, from 0.41 (1 year) to 0.56 (5 years), reflecting how their relationship changes across market environments.
PBE vs. PBD - Sectors Allocation Comparison
Sectors
PBE
PBD
Healthcare
-
Financial Services
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
PBE
PBD
-
Financial Services
PBE
PBD
Basic Materials
PBE
-
PBD
Communication Services
PBE
-
PBD
-
Consumer Cyclical
PBE
-
PBD
Consumer Defensive
PBE
-
PBD
Energy
PBE
-
PBD
Industrials
PBE
-
PBD
Real Estate
PBE
-
PBD
-
Technology
PBE
-
PBD
Utilities
PBE
-
PBD
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. PBD — Risk / Return Rank
PBE
PBD
PBE vs. PBD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Invesco Global Clean Energy ETF (PBD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | PBD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.33 | ||
| Sortino ratioReturn per unit of downside risk | -2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.61 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | 2.59 | 8.65 | -6.05 |
| Martin ratioReturn relative to average drawdown | 7.27 | 26.96 | -19.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PBE | PBD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.63 | 3.96 | -2.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | -0.13 | +0.27 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | 0.35 | -0.04 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.03 | +0.30 |
Drawdowns
PBE vs. PBD - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum PBD drawdown of -78.60%. Use the drawdown chart below to compare losses from any high point for PBE and PBD.
Loading charts...
Drawdown Indicators
| PBE | PBD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -78.60% | +32.91% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -10.70% | -1.03% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | -52.45% | +30.02% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -69.15% | +34.44% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -75.40% | +37.56% |
Current DrawdownCurrent decline from peak | -3.62% | -39.02% | +35.40% |
Average DrawdownAverage peak-to-trough decline | -16.24% | -53.40% | +37.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 3.43% | +0.74% |
Volatility
PBE vs. PBD - Volatility Comparison
The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 5.63%, while Invesco Global Clean Energy ETF (PBD) has a volatility of 8.57%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than PBD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | PBD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.63% | 8.57% | -2.94% |
Volatility (6M)Calculated over the trailing 6-month period | 13.27% | 17.00% | -3.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.71% | 23.41% | -4.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.54% | 28.37% | -5.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.92% | 27.26% | -2.34% |
PBE vs. PBD - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is lower than PBD's 0.75% expense ratio.
Dividends
PBE vs. PBD - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.05%, less than PBD's 1.63% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBD Invesco Global Clean Energy ETF | 1.63% | 2.71% | 1.81% | 2.85% | 2.98% | 0.67% | 0.48% | 1.83% | 1.86% | 1.76% | 2.04% | 1.24% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.05% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
PBE and PBD have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PBD has higher volatility (8.57%) compared to PBE (5.63%). In terms of maximum drawdown, PBE dropped -45.69% vs PBD's -78.60%.
On 10-year performance, PBD leads with 9.45% vs 7.55% for PBE. On fees, PBE is cheaper at 0.59% per year. On volatility, PBE has been the lower-risk option at 5.63%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PBD has performed better with a 9.45% return vs 7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PBE is cheaper with a 0.59% expense ratio, compared with 0.75% for PBD.
PBD has the higher dividend yield at 1.63%, compared with 1.05% for PBE.
PBE is categorized as Health & Biotech Equities, while PBD is Alternative Energy Equities. PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while PBD tracks WilderHill New Energy Global Innovation index. Their fees differ too: 0.59% for PBE and 0.75% for PBD.
PBD currently has the higher Sharpe Ratio (3.96 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and PBD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer